A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls

Publisher： Karger

E-ISSN： 1660-2862|16|5-6|398-406

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.16, Iss.5-6, 2016-07, pp. : 398-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Cerebrospinal Fluid Aβ38/Aβ42 Ratio in Alzheimer Disease

By  

Neurodegenerative Diseases, Vol. 2, Iss. 5, 2006-02 ,pp. : 242-245

Karger

Access to resources Recommend Favorite

Analysis of APL1β28, a Surrogate Marker for Alzheimer Aβ42, Indicates Altered Precision of γ-Cleavage in the Brains of Alzheimer Disease Patients

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-02 ,pp. : 42-45

Karger

Access to resources Recommend Favorite

Aβ Immunotherapy: Lessons Learned for Potential Treatment of Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 2, Iss. 5, 2006-02 ,pp. : 255-260

Karger

Access to resources Recommend Favorite

Intraneuronal Aβ Accumulation, Amyloid Plaques, and Synapse Pathology in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-01 ,pp. : 56-59

Karger

Access to resources Recommend Favorite

Prefibrillar Tau Oligomers in Mild Cognitive Impairment and Alzheimer's Disease

By  

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-09 ,pp. : 151-153

Karger

Access to resources Recommend Favorite